Episode 62: Financing Biotech and Scaling Innovation at Mercury with Key Opinion Leader Ben Kromnick
Are you facing challenges in navigating the biotech funding landscape and building lasting relationships with investors and partners?
In this episode, Ben Kromnick, Head of Healthcare and Life Sciences at Mercury, sits down with James Zanewicz, JD, LLM, RTTP, to share his expertise on how to successfully finance and scale biotech companies. He discusses the key stages of growth for biotech startups, from securing initial funding to building lasting relationships with investors. Ben also provides insight into Mercury’s approach to helping founders innovate, navigate financial challenges, and develop the infrastructure needed to succeed in the competitive biotech industry.
In this episode, you’ll discover:
- How biotech startups can strategically secure funding at various growth stages.
- The role of innovation, partnerships, and investor relations in scaling biotech companies.
- Key lessons from Mercury’s work with founders in the biotech and health tech sectors.
Tune in to learn how Ben Kromnick and Mercury are shaping the future of biotech financing.
Links:
Connect with Ben Kromnick and learn more about Mercury.
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out the HITLAB Innovators Summit 2024, December 2-4.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
